Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the ...

In this episode of Denatured, you'll hear from Jason Jones, head of global business development at Cellular Origins and ...

Cell and gene therapy (CGT) manufacturers can struggle to move from lab-scale to clinical-scale production. Automation can help but, to make a success of the transition, developers must be willing to ...

A novel approach to automating cell therapy manufacturing using industry-standard equipment can potentially reduce human errors, deliver higher quality product, and lower manufacturing costs by ...

To reduce engineering time and get their products to market faster, many device makers are turning to standardized automated ...

Engineers have created new technology that can move cells without touching them, enabling critical tasks that currently require large pieces of lab equipment to be carried out on a benchtop device.

Discovery of efficient anti-cancer drugs and drug combinations is essential for therapy success. Therefore, it is crucial that new methods for efficient drug efficacy testing are developed to support ...

Biologics and cell therapy programs face increasing pressure to generate high-quality cell lines and physiologically relevant 3D models, faster and with greater reproducibility. Integrated automation ...

This article and associated images are based on a poster originally authored by Wambeke E, Boribong BP, Sinha H, Patel M, Vo PQN, Chin AB, Ellouzi A, Barlan K and Hirukawa A and presented at ELRIG ...

ABB Robotics will demonstrate a range of advanced automation technologies at MACH 2026, showcasing how manufacturers can increase productivity, improve flexibility and accelerate digital ...